 | • レポートコード：MRC2Q12-19201 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、低用量避妊ピルのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 低用量避妊ピルのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 低用量避妊ピルの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 低用量避妊ピルのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの低用量避妊ピルの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の低用量避妊ピルの売上および2028年までの予測に焦点を当てています。 低用量避妊ピルのグローバル主要企業には、Lo Loestrin、Slynd、Balcoltra、Nextstellis、Taytulla、Bayer、Phexxi、Viatris、Tyblume、Twirla、Xulane、Alloy、Pfizer、Organon、Janssenなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 低用量避妊ピル市場は、タイプとアプリケーションによって区分されます。世界の低用量避妊ピル市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 エチニルエストラジオール、ドロスピレノン、レボノルゲストレル、ノルエチンドロン、その他 【アプリケーション別セグメント】 オフライン販売、オンライン販売 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 低用量避妊ピル製品概要 - タイプ別市場（エチニルエストラジオール、ドロスピレノン、レボノルゲストレル、ノルエチンドロン、その他） - アプリケーション別市場（オフライン販売、オンライン販売） - 調査の目的 ・エグゼクティブサマリー - 世界の低用量避妊ピル販売量予測2017-2028 - 世界の低用量避妊ピル売上予測2017-2028 - 低用量避妊ピルの地域別販売量 - 低用量避妊ピルの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別低用量避妊ピル販売量 - 主要メーカー別低用量避妊ピル売上 - 主要メーカー別低用量避妊ピル価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（エチニルエストラジオール、ドロスピレノン、レボノルゲストレル、ノルエチンドロン、その他） - 低用量避妊ピルのタイプ別販売量 - 低用量避妊ピルのタイプ別売上 - 低用量避妊ピルのタイプ別価格 ・アプリケーション別市場規模（オフライン販売、オンライン販売） - 低用量避妊ピルのアプリケーション別販売量 - 低用量避妊ピルのアプリケーション別売上 - 低用量避妊ピルのアプリケーション別価格 ・北米市場 - 北米の低用量避妊ピル市場規模（タイプ別、アプリケーション別） - 主要国別の低用量避妊ピル市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの低用量避妊ピル市場規模（タイプ別、アプリケーション別） - 主要国別の低用量避妊ピル市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の低用量避妊ピル市場規模（タイプ別、アプリケーション別） - 主要国別の低用量避妊ピル市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の低用量避妊ピル市場規模（タイプ別、アプリケーション別） - 主要国別の低用量避妊ピル市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの低用量避妊ピル市場規模（タイプ別、アプリケーション別） - 主要国別の低用量避妊ピル市場規模（トルコ、サウジアラビア） ・企業情報 Lo Loestrin、Slynd、Balcoltra、Nextstellis、Taytulla、Bayer、Phexxi、Viatris、Tyblume、Twirla、Xulane、Alloy、Pfizer、Organon、Janssen ・産業チェーン及び販売チャネル分析 - 低用量避妊ピルの産業チェーン分析 - 低用量避妊ピルの原材料 - 低用量避妊ピルの生産プロセス - 低用量避妊ピルの販売及びマーケティング - 低用量避妊ピルの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 低用量避妊ピルの産業動向 - 低用量避妊ピルのマーケットドライバー - 低用量避妊ピルの課題 - 低用量避妊ピルの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Low-dose Birth Control Pill is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Low-dose Birth Control Pill is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Low-dose Birth Control Pill is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Low-dose Birth Control Pill include Lo Loestrin, Slynd, Balcoltra, Nextstellis, Taytulla, Bayer, Phexxi, Viatris and Tyblume, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Low-dose Birth Control Pill manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Low-dose Birth Control Pill market. Further, it explains the major drivers and regional dynamics of the global Low-dose Birth Control Pill market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Lo Loestrin
Slynd
Balcoltra
Nextstellis
Taytulla
Bayer
Phexxi
Viatris
Tyblume
Twirla
Xulane
Alloy
Pfizer
Organon
Janssen
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by channel segments based on sales, price, and value for the period 2017-2028.
Low-dose Birth Control Pill Segment by Type
Ethinyl Estradiol
Drospirenone
Levonorgestrel
Norethindrone
Others
Low-dose Birth Control Pill Segment by Channel
Offline Sales
Online Sales
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Low-dose Birth Control Pill market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Low-dose Birth Control Pill, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Low-dose Birth Control Pill, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Low-dose Birth Control Pill, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Low-dose Birth Control Pill sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Low-dose Birth Control Pill market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Low-dose Birth Control Pill sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lo Loestrin, Slynd, Balcoltra, Nextstellis, Taytulla, Bayer, Phexxi, Viatris and Tyblume, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Low-dose Birth Control Pill in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Low-dose Birth Control Pill manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by channel and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by channel and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by channel and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by channel and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by channel and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Low-dose Birth Control Pill sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Low-dose Birth Control Pill Product Introduction
1.2 Market by Type
1.2.1 Global Low-dose Birth Control Pill Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Ethinyl Estradiol
1.2.3 Drospirenone
1.2.4 Levonorgestrel
1.2.5 Norethindrone
1.2.6 Others
1.3 Market by Channel
1.3.1 Global Low-dose Birth Control Pill Market Size Growth Rate by Channel, 2017 VS 2021 VS 2028
1.3.2 Offline Sales
1.3.3 Online Sales
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Low-dose Birth Control Pill Sales Estimates and Forecasts 2017-2028
2.2 Global Low-dose Birth Control Pill Revenue Estimates and Forecasts 2017-2028
2.3 Global Low-dose Birth Control Pill Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Low-dose Birth Control Pill Sales by Region
2.4.1 Global Low-dose Birth Control Pill Sales by Region (2017-2022)
2.4.2 Global Sales Low-dose Birth Control Pill by Region (2023-2028)
2.5 Global Low-dose Birth Control Pill Revenue by Region
2.5.1 Global Low-dose Birth Control Pill Revenue by Region (2017-2022)
2.5.2 Global Low-dose Birth Control Pill Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Low-dose Birth Control Pill Sales by Manufacturers
3.1.1 Global Top Low-dose Birth Control Pill Manufacturers by Sales (2017-2022)
3.1.2 Global Low-dose Birth Control Pill Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Low-dose Birth Control Pill in 2021
3.2 Global Low-dose Birth Control Pill Revenue by Manufacturers
3.2.1 Global Low-dose Birth Control Pill Revenue by Manufacturers (2017-2022)
3.2.2 Global Low-dose Birth Control Pill Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Low-dose Birth Control Pill Revenue in 2021
3.3 Global Low-dose Birth Control Pill Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Low-dose Birth Control Pill Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Low-dose Birth Control Pill Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Low-dose Birth Control Pill Sales by Type
4.1.1 Global Low-dose Birth Control Pill Historical Sales by Type (2017-2022)
4.1.2 Global Low-dose Birth Control Pill Forecasted Sales by Type (2023-2028)
4.1.3 Global Low-dose Birth Control Pill Sales Market Share by Type (2017-2028)
4.2 Global Low-dose Birth Control Pill Revenue by Type
4.2.1 Global Low-dose Birth Control Pill Historical Revenue by Type (2017-2022)
4.2.2 Global Low-dose Birth Control Pill Forecasted Revenue by Type (2023-2028)
4.2.3 Global Low-dose Birth Control Pill Revenue Market Share by Type (2017-2028)
4.3 Global Low-dose Birth Control Pill Price by Type
4.3.1 Global Low-dose Birth Control Pill Price by Type (2017-2022)
4.3.2 Global Low-dose Birth Control Pill Price Forecast by Type (2023-2028)
5 Market Size by Channel
5.1 Global Low-dose Birth Control Pill Sales by Channel
5.1.1 Global Low-dose Birth Control Pill Historical Sales by Channel (2017-2022)
5.1.2 Global Low-dose Birth Control Pill Forecasted Sales by Channel (2023-2028)
5.1.3 Global Low-dose Birth Control Pill Sales Market Share by Channel (2017-2028)
5.2 Global Low-dose Birth Control Pill Revenue by Channel
5.2.1 Global Low-dose Birth Control Pill Historical Revenue by Channel (2017-2022)
5.2.2 Global Low-dose Birth Control Pill Forecasted Revenue by Channel (2023-2028)
5.2.3 Global Low-dose Birth Control Pill Revenue Market Share by Channel (2017-2028)
5.3 Global Low-dose Birth Control Pill Price by Channel
5.3.1 Global Low-dose Birth Control Pill Price by Channel (2017-2022)
5.3.2 Global Low-dose Birth Control Pill Price Forecast by Channel (2023-2028)
6 North America
6.1 North America Low-dose Birth Control Pill Market Size by Type
6.1.1 North America Low-dose Birth Control Pill Sales by Type (2017-2028)
6.1.2 North America Low-dose Birth Control Pill Revenue by Type (2017-2028)
6.2 North America Low-dose Birth Control Pill Market Size by Channel
6.2.1 North America Low-dose Birth Control Pill Sales by Channel (2017-2028)
6.2.2 North America Low-dose Birth Control Pill Revenue by Channel (2017-2028)
6.3 North America Low-dose Birth Control Pill Market Size by Country
6.3.1 North America Low-dose Birth Control Pill Sales by Country (2017-2028)
6.3.2 North America Low-dose Birth Control Pill Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Low-dose Birth Control Pill Market Size by Type
7.1.1 Europe Low-dose Birth Control Pill Sales by Type (2017-2028)
7.1.2 Europe Low-dose Birth Control Pill Revenue by Type (2017-2028)
7.2 Europe Low-dose Birth Control Pill Market Size by Channel
7.2.1 Europe Low-dose Birth Control Pill Sales by Channel (2017-2028)
7.2.2 Europe Low-dose Birth Control Pill Revenue by Channel (2017-2028)
7.3 Europe Low-dose Birth Control Pill Market Size by Country
7.3.1 Europe Low-dose Birth Control Pill Sales by Country (2017-2028)
7.3.2 Europe Low-dose Birth Control Pill Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Low-dose Birth Control Pill Market Size by Type
8.1.1 Asia Pacific Low-dose Birth Control Pill Sales by Type (2017-2028)
8.1.2 Asia Pacific Low-dose Birth Control Pill Revenue by Type (2017-2028)
8.2 Asia Pacific Low-dose Birth Control Pill Market Size by Channel
8.2.1 Asia Pacific Low-dose Birth Control Pill Sales by Channel (2017-2028)
8.2.2 Asia Pacific Low-dose Birth Control Pill Revenue by Channel (2017-2028)
8.3 Asia Pacific Low-dose Birth Control Pill Market Size by Region
8.3.1 Asia Pacific Low-dose Birth Control Pill Sales by Region (2017-2028)
8.3.2 Asia Pacific Low-dose Birth Control Pill Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Low-dose Birth Control Pill Market Size by Type
9.1.1 Latin America Low-dose Birth Control Pill Sales by Type (2017-2028)
9.1.2 Latin America Low-dose Birth Control Pill Revenue by Type (2017-2028)
9.2 Latin America Low-dose Birth Control Pill Market Size by Channel
9.2.1 Latin America Low-dose Birth Control Pill Sales by Channel (2017-2028)
9.2.2 Latin America Low-dose Birth Control Pill Revenue by Channel (2017-2028)
9.3 Latin America Low-dose Birth Control Pill Market Size by Country
9.3.1 Latin America Low-dose Birth Control Pill Sales by Country (2017-2028)
9.3.2 Latin America Low-dose Birth Control Pill Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Low-dose Birth Control Pill Market Size by Type
10.1.1 Middle East and Africa Low-dose Birth Control Pill Sales by Type (2017-2028)
10.1.2 Middle East and Africa Low-dose Birth Control Pill Revenue by Type (2017-2028)
10.2 Middle East and Africa Low-dose Birth Control Pill Market Size by Channel
10.2.1 Middle East and Africa Low-dose Birth Control Pill Sales by Channel (2017-2028)
10.2.2 Middle East and Africa Low-dose Birth Control Pill Revenue by Channel (2017-2028)
10.3 Middle East and Africa Low-dose Birth Control Pill Market Size by Country
10.3.1 Middle East and Africa Low-dose Birth Control Pill Sales by Country (2017-2028)
10.3.2 Middle East and Africa Low-dose Birth Control Pill Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lo Loestrin
11.1.1 Lo Loestrin Corporation Information
11.1.2 Lo Loestrin Overview
11.1.3 Lo Loestrin Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lo Loestrin Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lo Loestrin Recent Developments
11.2 Slynd
11.2.1 Slynd Corporation Information
11.2.2 Slynd Overview
11.2.3 Slynd Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Slynd Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Slynd Recent Developments
11.3 Balcoltra
11.3.1 Balcoltra Corporation Information
11.3.2 Balcoltra Overview
11.3.3 Balcoltra Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Balcoltra Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Balcoltra Recent Developments
11.4 Nextstellis
11.4.1 Nextstellis Corporation Information
11.4.2 Nextstellis Overview
11.4.3 Nextstellis Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nextstellis Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nextstellis Recent Developments
11.5 Taytulla
11.5.1 Taytulla Corporation Information
11.5.2 Taytulla Overview
11.5.3 Taytulla Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Taytulla Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Taytulla Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Overview
11.6.3 Bayer Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bayer Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bayer Recent Developments
11.7 Phexxi
11.7.1 Phexxi Corporation Information
11.7.2 Phexxi Overview
11.7.3 Phexxi Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Phexxi Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Phexxi Recent Developments
11.8 Viatris
11.8.1 Viatris Corporation Information
11.8.2 Viatris Overview
11.8.3 Viatris Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Viatris Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Viatris Recent Developments
11.9 Tyblume
11.9.1 Tyblume Corporation Information
11.9.2 Tyblume Overview
11.9.3 Tyblume Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Tyblume Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Tyblume Recent Developments
11.10 Twirla
11.10.1 Twirla Corporation Information
11.10.2 Twirla Overview
11.10.3 Twirla Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Twirla Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Twirla Recent Developments
11.11 Xulane
11.11.1 Xulane Corporation Information
11.11.2 Xulane Overview
11.11.3 Xulane Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Xulane Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Xulane Recent Developments
11.12 Alloy
11.12.1 Alloy Corporation Information
11.12.2 Alloy Overview
11.12.3 Alloy Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Alloy Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Alloy Recent Developments
11.13 Pfizer
11.13.1 Pfizer Corporation Information
11.13.2 Pfizer Overview
11.13.3 Pfizer Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Pfizer Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Pfizer Recent Developments
11.14 Organon
11.14.1 Organon Corporation Information
11.14.2 Organon Overview
11.14.3 Organon Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Organon Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Organon Recent Developments
11.15 Janssen
11.15.1 Janssen Corporation Information
11.15.2 Janssen Overview
11.15.3 Janssen Low-dose Birth Control Pill Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Janssen Low-dose Birth Control Pill Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Janssen Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Low-dose Birth Control Pill Industry Chain Analysis
12.2 Low-dose Birth Control Pill Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Low-dose Birth Control Pill Production Mode & Process
12.4 Low-dose Birth Control Pill Sales and Marketing
12.4.1 Low-dose Birth Control Pill Sales Channels
12.4.2 Low-dose Birth Control Pill Distributors
12.5 Low-dose Birth Control Pill Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Low-dose Birth Control Pill Industry Trends
13.2 Low-dose Birth Control Pill Market Drivers
13.3 Low-dose Birth Control Pill Market Challenges
13.4 Low-dose Birth Control Pill Market Restraints
14 Key Findings in The Global Low-dose Birth Control Pill Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer